Insider · CIK 0001185945
Chris A Rallis
Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing Nov 20, 2023, latest May 12, 2026.
In brief
Chris A Rallis files SEC Form 4 as director at FENC (FENNEC PHARMACEUTICALS INC.). Since Nov 20, 2023, Chris A Rallis has reported 0 open-market buys worth $0 and 8 open-market sells worth $157k, the latest filed on May 12, 2026.
A track record needs three past buys with six months of prices behind them; Chris A Rallis has 0, so none is measured yet.
The newest scored trade: sold $59k of FENC on May 11, 2026, filed May 12, 2026, scored 0 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $75k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FENC: FENNEC PHARMACEUTICALS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | FENNEC PHARMACEUTICALS INC. | $59k 8,346 shares | -12% | +23% from low-28% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $16k 1,775 shares | -3% | +115% from low-13% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $9,746 1,119 shares | -2% | +112% from low-4% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $6,975 1,409 shares | -3% | +26% from low-29% from high | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $8,089 1,186 shares | -2% | - | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $39k 6,409 shares | -11% | - | |
| 0Weak | FENNEC PHARMACEUTICALS INC. | $15k 1,390 shares | -3% | +79% from low0% from high | |
| 3Weak | FENNEC PHARMACEUTICALS INC. | $2,219 269 shares | -1% | +32% from low-17% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 11, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 8,346 0.02% of outstanding | $59k | May 11, 2026 | none |
| Oct 10, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 1,775 0.01% of outstanding | $16k | Oct 10, 2025 | none |
| Feb 14, 2025 | FENC FENNEC PHARMACEUTICALS INC. | 1,186 0.00% of outstanding | $8,089 | Feb 14, 2025 | $39k |
| Dec 2, 2024 | FENC FENNEC PHARMACEUTICALS INC. | 6,409 0.02% of outstanding | $39k | Dec 2, 2024 | $6,369 |
Transactions
Every row this insider has filed, 24 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionderivative | +20,000 | $8.70 | $174k | 200,000 | Jun 10, 2026 |
| May 11, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares10b5-1 | +14,344 | $2.44 | $35k | 71,423 | May 12, 2026 |
| May 11, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -8,346 | $7.04 | $59k | 63,077 | May 12, 2026 |
| May 11, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionderivative10b5-1 | -14,344 | $2.44 | $35k | 186,189 | May 12, 2026 |
| Oct 10, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares10b5-1 | +4,062 | $1.23 | $4,996 | 58,854 | Oct 14, 2025 |
| Oct 10, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -1,775 | $9.24 | $16k | 57,079 | Oct 14, 2025 |
| Oct 10, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Sharesderivative10b5-1 | -4,062 | $1.23 | $4,996 | 174,344 | Oct 14, 2025 |
| Jul 7, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares10b5-1 | +2,127 | $2.35 | $4,998 | 55,911 | Jul 7, 2025 |
| Jul 7, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -1,119 | $8.71 | $9,746 | 54,792 | Jul 7, 2025 |
| Jul 7, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Sharesderivative10b5-1 | -2,127 | $2.35 | $4,998 | 178,406 | Jul 7, 2025 |
| Jun 3, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionderivative | +20,000 | $7.88 | $158k | 200,533 | Jun 4, 2025 |
| Apr 11, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares10b5-1 | +2,173 | $2.30 | $4,998 | 55,193 | Apr 11, 2025 |
| Apr 11, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -1,409 | $4.95 | $6,975 | 53,784 | Apr 11, 2025 |
| Apr 11, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Sharesderivative10b5-1 | -2,173 | $2.30 | $4,998 | 180,533 | Apr 11, 2025 |
| Feb 14, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares10b5-1 | +1,992 | $2.51 | $5,000 | 54,206 | Feb 14, 2025 |
| Feb 14, 2025 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -1,186 | $6.82 | $8,089 | 53,020 | Feb 14, 2025 |
| Feb 14, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Sharesderivative10b5-1 | -1,992 | $2.51 | $5,000 | 182,706 | Feb 14, 2025 |
| Dec 2, 2024 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares10b5-1 | +10,000 | $2.69 | $27k | 58,623 | Dec 2, 2024 |
| Dec 2, 2024 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -6,409 | $6.14 | $39k | 52,214 | Dec 2, 2024 |
| Dec 2, 2024 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Sharesderivative10b5-1 | -10,000 | $2.69 | $27k | 184,698 | Dec 2, 2024 |
| Dec 26, 2023 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -1,390 | $10.90 | $15k | 44,788 | Dec 28, 2023 |
| Dec 26, 2023 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares10b5-1 | +3,144 | $1.59 | $4,999 | 46,178 | Dec 28, 2023 |
| Dec 26, 2023 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Sharesderivative10b5-1 | -3,144 | $1.59 | $4,999 | 184,168 | Dec 28, 2023 |
| Nov 20, 2023 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common Shares10b5-1 | -269 | $8.25 | $2,219 | 43,034 | Nov 20, 2023 |
Questions about Chris A Rallis
Answered from the filings on this page, as of the latest one.
Is Chris A Rallis buying or selling?
In the last 12 months Chris A Rallis reported 0 open-market buys worth $0 and 2 open-market sells worth $75k on SEC Form 4; the latest was sold $59k of FENC on May 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Chris A Rallis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Chris A Rallis has 0.
Where does Chris A Rallis file Form 4?
Chris A Rallis has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.